Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Cyanine dyes in the mitochondria-targeting photodynamic and photothermal therapy

Z. Kejík, J. Hajduch, N. Abramenko, F. Vellieux, K. Veselá, JL. Fialová, K. Petrláková, K. Kučnirová, R. Kaplánek, A. Tatar, M. Skaličková, M. Masařík, P. Babula, P. Dytrych, D. Hoskovec, P. Martásek, M. Jakubek

. 2024 ; 7 (1) : 180. [pub] 20240813

Status neindexováno Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24018046

Grantová podpora
SVV260637 Univerzita Karlova v Praze (Charles University)
SVV260521 Univerzita Karlova v Praze (Charles University)
UNCE 204064 Univerzita Karlova v Praze (Charles University)
Progres LF1 Q38 Univerzita Karlova v Praze (Charles University)
Progres LF1 Q27 Univerzita Karlova v Praze (Charles University)
Cooperatio ONCO Univerzita Karlova v Praze (Charles University)
LM2023053 Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
TN02000109 Technologická Agentura České Republiky (Technological Agency of the Czech Republic)
NU22-08-00160 Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
NU21-08-00407 Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
MUNI/A/1587/2023 Masarykova Univerzita (Masaryk University)

Mitochondrial dysregulation plays a significant role in the carcinogenesis. On the other hand, its destabilization strongly represses the viability and metastatic potential of cancer cells. Photodynamic and photothermal therapies (PDT and PTT) target mitochondria effectively, providing innovative and non-invasive anticancer therapeutic modalities. Cyanine dyes, with strong mitochondrial selectivity, show significant potential in enhancing PDT and PTT. The potential and limitations of cyanine dyes for mitochondrial PDT and PTT are discussed, along with their applications in combination therapies, theranostic techniques, and optimal delivery systems. Additionally, novel approaches for sonodynamic therapy using photoactive cyanine dyes are presented, highlighting advances in cancer treatment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24018046
003      
CZ-PrNML
005      
20241016081809.0
007      
ta
008      
241008s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s42004-024-01256-6 $2 doi
035    __
$a (PubMed)39138299
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kejík, Zdeněk $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Prague, Czech Republic. Zdenek.Kejik@lf1.cuni.cz $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00, Prague, Czech Republic. Zdenek.Kejik@lf1.cuni.cz $1 https://orcid.org/0000000222154890
245    10
$a Cyanine dyes in the mitochondria-targeting photodynamic and photothermal therapy / $c Z. Kejík, J. Hajduch, N. Abramenko, F. Vellieux, K. Veselá, JL. Fialová, K. Petrláková, K. Kučnirová, R. Kaplánek, A. Tatar, M. Skaličková, M. Masařík, P. Babula, P. Dytrych, D. Hoskovec, P. Martásek, M. Jakubek
520    9_
$a Mitochondrial dysregulation plays a significant role in the carcinogenesis. On the other hand, its destabilization strongly represses the viability and metastatic potential of cancer cells. Photodynamic and photothermal therapies (PDT and PTT) target mitochondria effectively, providing innovative and non-invasive anticancer therapeutic modalities. Cyanine dyes, with strong mitochondrial selectivity, show significant potential in enhancing PDT and PTT. The potential and limitations of cyanine dyes for mitochondrial PDT and PTT are discussed, along with their applications in combination therapies, theranostic techniques, and optimal delivery systems. Additionally, novel approaches for sonodynamic therapy using photoactive cyanine dyes are presented, highlighting advances in cancer treatment.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Hajduch, Jan $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Prague, Czech Republic $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00, Prague, Czech Republic
700    1_
$a Abramenko, Nikita $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Prague, Czech Republic $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00, Prague, Czech Republic
700    1_
$a Vellieux, Frédéric $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Prague, Czech Republic $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00, Prague, Czech Republic $1 https://orcid.org/0000000219225707
700    1_
$a Veselá, Kateřina $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Prague, Czech Republic $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00, Prague, Czech Republic
700    1_
$a Fialová, Jindřiška Leischner $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Prague, Czech Republic
700    1_
$a Petrláková, Kateřina $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, CZ-625 00, Brno, Czech Republic
700    1_
$a Kučnirová, Kateřina $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Prague, Czech Republic $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00, Prague, Czech Republic
700    1_
$a Kaplánek, Robert $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Prague, Czech Republic $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00, Prague, Czech Republic
700    1_
$a Tatar, Ameneh $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Prague, Czech Republic $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00, Prague, Czech Republic $1 https://orcid.org/0000000185132106
700    1_
$a Skaličková, Markéta $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Prague, Czech Republic $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00, Prague, Czech Republic
700    1_
$a Masařík, Michal $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Prague, Czech Republic $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00, Prague, Czech Republic $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, CZ-625 00, Brno, Czech Republic $u Department of Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
700    1_
$a Babula, Petr $u Department of Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
700    1_
$a Dytrych, Petr $u 1st Department of Surgery-Department of Abdominal, Thoracic Surgery and Traumatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 121 08, Prague, Czech Republic
700    1_
$a Hoskovec, David $u 1st Department of Surgery-Department of Abdominal, Thoracic Surgery and Traumatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 121 08, Prague, Czech Republic
700    1_
$a Martásek, Pavel $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00, Prague, Czech Republic. Pavel.Martasek@lf1.cuni.cz $1 https://orcid.org/0000000208398370
700    1_
$a Jakubek, Milan $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Prague, Czech Republic. Milan.Jakubek@lf1.cuni.cz $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00, Prague, Czech Republic. Milan.Jakubek@lf1.cuni.cz $1 https://orcid.org/0000000173233903
773    0_
$w MED00215626 $t Communications chemistry $x 2399-3669 $g Roč. 7, č. 1 (2024), s. 180
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39138299 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241008 $b ABA008
991    __
$a 20241016081804 $b ABA008
999    __
$a ok $b bmc $g 2196441 $s 1229997
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 7 $c 1 $d 180 $e 20240813 $i 2399-3669 $m Communications chemistry $n Commun Chem $x MED00215626
GRA    __
$a SVV260637 $p Univerzita Karlova v Praze (Charles University)
GRA    __
$a SVV260521 $p Univerzita Karlova v Praze (Charles University)
GRA    __
$a UNCE 204064 $p Univerzita Karlova v Praze (Charles University)
GRA    __
$a Progres LF1 Q38 $p Univerzita Karlova v Praze (Charles University)
GRA    __
$a Progres LF1 Q27 $p Univerzita Karlova v Praze (Charles University)
GRA    __
$a Cooperatio ONCO $p Univerzita Karlova v Praze (Charles University)
GRA    __
$a LM2023053 $p Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
GRA    __
$a TN02000109 $p Technologická Agentura České Republiky (Technological Agency of the Czech Republic)
GRA    __
$a NU22-08-00160 $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
GRA    __
$a NU21-08-00407 $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
GRA    __
$a MUNI/A/1587/2023 $p Masarykova Univerzita (Masaryk University)
LZP    __
$a Pubmed-20241008

Najít záznam

Citační ukazatele

Možnosti archivace